ÇáãÓÇÚÏ ÇáÔÎÕí ÇáÑÞãí

ãÔÇåÏÉ ÇáäÓÎÉ ßÇãáÉ : åÇÇÇÇÇÇÇÇÇÇÇã ÌÏÇÇÇÇ - ÃÏæíÉ


Maged
21-02-2006, 10:48 AM
áÇ ÃÚÑÝ ãÏì ÕÍÉ åÐÇ ÇáßáÇã æáßä ãä Çáãåã Ãä íÊÃßÏ ßá æÇÍÏ ãä ØÈíÈå Úä Ðáß. ÚãæãÇ ßá ÏæÇÁ áå ÂËÇÑ ÌÇäÈíÉ ÞÏ áÇ Êßæä ãÍãæÏÉ.


Very Important

åÇÇÇÇÇÇÇÇÇÇÇã ÌÏÇÇÇÇ

ÇáÊÞÑíÑ ÇáãÑÝÞ ÃÏäÇå Êã ÊæÒíÚå Úáí ØáÈÉ æãæÙÝí ÇáÌÇãÚÉ ÇáÃãÑíßíÉ Ýí ãÕÑ, ÊÍÐíÑÇð ãä ÚÏÉ ÃÏæíÉ ÊÃßÏ ááÍßæãÉ ÇáÃãÑíßíÉ ÊÃËíÑåÇ ÇáãÈÇÔÑ æÚáí ÇáÓíÏÇÊ ÎÕíÕÇð, ÍíË ÃäåÇ ÊÓÈÈ ÌáØÉ Ýí ÇáÏãÇÛ





ÇáãæÖæÚ ÎØíÑ ÍíË ãÇÒÇáÊ åÐå ÇáÃÓãÇÁ ÊÊÏÇæá æÈÔßá ØÈíÚí ÌÏÇð Ýí ÕíÏáíÇÊ ÇáÏæá ÇáÚÑÈíÉ





Upon the recommendation of the FDA (Food and Drug Administration), all drugs containing phenylpronalamine should be withdrawn from the U.S. market. This decision was based on a study conducted to investigate the risk of hemorrhagic stroke associated with the use of phenylpronalamine. The study reported an association between phenylpronalamine use and hemorrhagic stroke in women. The increase risk of hemorrhagic stroke was for women using phenylpronalamine for weight control and as a nasal decongestant product. Although the study showed that the risk of hemorrhagic stoke is found mostly in women, men may also be at risk.

The following is a list of all drugs containing phenylpronalamine that are still available and in use in the Egyptian market:

1. Conta-Flu ßæäÊÇ- Ýáæ

2. Antiflu ÃäÊí Ýáæ

3. Nova-C-M äæÝÇ – Óì - Åã

4. Coldact ßæáÏÇßÊ

5. Flustop Ýáæ ÓÊæÈ

6. Flurest Ýáæ ÑÓÊ

7. Rhinomol Ñíäæãæá

8. Pararhinol ÈÇÑÇ Ñíäæá

9. Michaelon ãíßÇáíæä

10. Noflu äæÝáæ

11. Coricidin D ßæÑíÓíÏíä - Ïì

12. Rhinogesic Ñíäæ ÌíÓíß

13. Contact 12 ßæäÊÇßÊ 12

14. Eskornade ÃÓßæÑäíÏ

15. Night and Day äÇíÊ ÂäÏ ÏÇì ( Çááíá æÇáäåÇÑ)

16. Vegaskine Aduls Syrup ÝíÌÇÓßíä ÔÑÇÈ ááÈÇáÛíä

17. Sinutab Óíäæ ÊÇÈ

18. Rhinopront Syrup ÑíäæÈÑæäÊ ÔÑÇÈ

19. Denoral ÏíäæÑÇá

20. Coflin ßæÝáíä

ÇÑÌæ ÚÏã ÇÓÊÎÏÇã ÇáÇÏæíÉ ÍÊì áæ æÕÝåÇ ÇáØÈíÈ

Please, avoid using the above drugs even if prescribed by your treating physician.

ÇäÔÑæåÇ áßá ãä ÊÚÑÝæä ÍãÇíÉ ááãÓáãíä

ÌÒÇßã Çááå ÎíÑÇð

ãÍãÏ ÇáÍíÇäí
21-02-2006, 10:12 PM
áÇåäÊ ÇÎææææææææææææææææí ÇáßÑíã



ÇÈíÖ æÌå


æÇÔßÑß Úáì ÇáÊäÈíå